Michael S. Lawrence

188.7k total citations · 4 hit papers
88 papers, 11.3k citations indexed

About

Michael S. Lawrence is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Michael S. Lawrence has authored 88 papers receiving a total of 11.3k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Molecular Biology, 37 papers in Cancer Research and 14 papers in Oncology. Recurrent topics in Michael S. Lawrence's work include Cancer Genomics and Diagnostics (34 papers), RNA modifications and cancer (14 papers) and Genomics and Chromatin Dynamics (13 papers). Michael S. Lawrence is often cited by papers focused on Cancer Genomics and Diagnostics (34 papers), RNA modifications and cancer (14 papers) and Genomics and Chromatin Dynamics (13 papers). Michael S. Lawrence collaborates with scholars based in United States, Germany and Spain. Michael S. Lawrence's co-authors include Gad Getz, Matthew Meyerson, Stacey Gabriel, Petar Stojanov, Eric S. Lander, Craig H. Mermel, Todd R. Golub, Levi A. Garraway, James Robinson and Gordon Saksena and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Michael S. Lawrence

82 papers receiving 11.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Discovery and saturation analysis of cancer genes across 21 tumour types

2014 2.1k citations Michael S. Lawrence, Levi A. Garraway et al. profile →
Pan-cancer patterns of somatic copy number alteration

2013 1.2k citations Michael S. Lawrence, Gad Getz et al. profile →
An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers

2013 832 citations Michael S. Lawrence, Gad Getz et al. profile →
Pan-cancer network analysis identifies combinations of rare somatic mutations across pathways and protein complexes

2014 588 citations Michael S. Lawrence, Gad Getz et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael S. Lawrence United States	39	7.8k	4.0k	2.4k	1.8k	1.4k	88	11.3k
Michael D. McLellan United States	20	6.7k 0.9×	4.1k 1.0×	2.4k 1.0×	2.3k 1.3×	1.4k 1.0×	35	11.7k
Christopher A. Miller United States	34	5.7k 0.7×	3.7k 0.9×	2.6k 1.1×	1.6k 0.9×	1.2k 0.9×	119	10.7k
Simon Forbes United Kingdom	21	7.6k 1.0×	4.0k 1.0×	2.8k 1.2×	1.4k 0.8×	1.2k 0.8×	46	11.2k
Shibin Zhou United States	38	8.5k 1.1×	3.8k 0.9×	4.1k 1.7×	2.2k 1.3×	1.4k 1.0×	66	14.9k
Alexander Dobrovic Australia	54	6.3k 0.8×	2.8k 0.7×	3.7k 1.5×	1.8k 1.0×	1.3k 0.9×	219	10.8k
John W.M. Martens Netherlands	61	6.8k 0.9×	4.8k 1.2×	4.4k 1.8×	1.5k 0.9×	833 0.6×	328	11.9k
Franziska Michor United States	60	6.0k 0.8×	4.6k 1.1×	3.8k 1.6×	2.1k 1.2×	876 0.6×	177	12.6k
Suet‐Feung Chin United Kingdom	44	6.8k 0.9×	5.7k 1.4×	3.2k 1.3×	1.5k 0.9×	1.2k 0.9×	98	11.0k
James D. Brenton United Kingdom	47	5.9k 0.8×	6.2k 1.5×	4.0k 1.7×	1.2k 0.7×	1.7k 1.2×	167	12.5k
Ron Kerkhoven Netherlands	40	10.8k 1.4×	3.5k 0.9×	4.7k 1.9×	1.9k 1.1×	756 0.5×	77	15.4k

Countries citing papers authored by Michael S. Lawrence

Since Specialization

Citations

This map shows the geographic impact of Michael S. Lawrence's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael S. Lawrence with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael S. Lawrence more than expected).

Fields of papers citing papers by Michael S. Lawrence

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael S. Lawrence. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael S. Lawrence. The network helps show where Michael S. Lawrence may publish in the future.

Co-authorship network of co-authors of Michael S. Lawrence

This figure shows the co-authorship network connecting the top 25 collaborators of Michael S. Lawrence. A scholar is included among the top collaborators of Michael S. Lawrence based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael S. Lawrence. Michael S. Lawrence is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bryan, Michael, Adam S. Fisch, Zoe Guan, et al.. (2025). Circulating tumor human papillomavirus DNA whole genome sequencing enables human papillomavirus–associated oropharynx cancer early detection. JNCI Journal of the National Cancer Institute. 118(1). 58–67.

Kawale, Ajinkya S., Xiaojuan Ran, Parasvi S. Patel, et al.. (2024). APOBEC3A induces DNA gaps through PRIMPOL and confers gap-associated therapeutic vulnerability. Science Advances. 10(3). eadk2771–eadk2771. 21 indexed citations

Sakhtemani, Ramin, et al.. (2024). Distinguishing preferences of human APOBEC3A and APOBEC3B for cytosines in hairpin loops, and reflection of these preferences in APOBEC-signature cancer genome mutations. Nature Communications. 15(1). 2369–2369. 13 indexed citations

Sanidas, Ioannis, et al.. (2023). Chromatin-bound protein colocalization analysis using bedGraph2Cluster and PanChIP. STAR Protocols. 4(1). 101991–101991. 1 indexed citations

Sanidas, Ioannis, Michael S. Lawrence, & Nicholas J. Dyson. (2023). Patterns in the tapestry of chromatin-bound RB. Trends in Cell Biology. 34(4). 288–298. 7 indexed citations

Yang, Haibo, Xiaojuan Ran, Parasvi S. Patel, et al.. (2023). The RNA m5C modification in R-loops as an off switch of Alt-NHEJ. Nature Communications. 14(1). 6114–6114. 22 indexed citations

Sakhtemani, Ramin, et al.. (2022). Human activation-induced deaminase lacks strong replicative strand bias or preference for cytosines in hairpin loops. Nucleic Acids Research. 50(9). 5145–5157. 4 indexed citations

Stanzione, Marcello, Jun Zhong, Edmond Wong, et al.. (2022). Translesion DNA synthesis mediates acquired resistance to olaparib plus temozolomide in small cell lung cancer. Science Advances. 8(19). eabn1229–eabn1229. 22 indexed citations

Bunting, Mark D., Marta Requesens, Adam Langenbucher, et al.. (2022). Extracellular matrix proteins regulate NK cell function in peripheral tissues. Science Advances. 8(11). eabk3327–eabk3327. 38 indexed citations

10.

Koh, Siang‐Boon, Kenneth N. Ross, Steven J. Isakoff, et al.. (2021). RASAL2 Confers Collateral MEK/EGFR Dependency in Chemoresistant Triple-Negative Breast Cancer. Clinical Cancer Research. 27(17). 4883–4897. 16 indexed citations

11.

Langenbucher, Adam, Ramin Sakhtemani, Elodie Bournique, et al.. (2021). An extended APOBEC3A mutation signature in cancer. Nature Communications. 12(1). 1602–1602. 68 indexed citations

12.

Vannam, Raghu, Eileen Hu, Johannes Kreuzer, et al.. (2021). Targeted degradation of the enhancer lysine acetyltransferases CBP and p300. Cell chemical biology. 28(4). 503–514.e12. 102 indexed citations

13.

Jalili, Pégah, Adam Langenbucher, Karmen Aguirre, et al.. (2020). Quantification of ongoing APOBEC3A activity in tumor cells by monitoring RNA editing at hotspots. Nature Communications. 11(1). 2971–2971. 70 indexed citations

14.

Karaayvaz, Mihriban, Adam Langenbucher, Srinivas Vinod Saladi, et al.. (2020). Aneuploidy and a deregulated DNA damage response suggest haploinsufficiency in breast tissues of BRCA2 mutation carriers. Science Advances. 6(5). eaay2611–eaay2611. 26 indexed citations

15.

Buisson, Rémi, Adam Langenbucher, Eugene E. Kwan, et al.. (2019). Passenger hotspot mutations in cancer driven by APOBEC3A and mesoscale genomic features. Science. 364(6447). 181 indexed citations

16.

Clarke, Thomas L., Ran Tang, Damayanti Chakraborty, et al.. (2019). Histone Lysine Methylation Dynamics Control EGFR DNA Copy-Number Amplification. Cancer Discovery. 10(2). 306–325. 39 indexed citations

17.

Sakhtemani, Ramin, et al.. (2019). Genome-wide mapping of regions preferentially targeted by the human DNA-cytosine deaminase APOBEC3A using uracil-DNA pulldown and sequencing. Journal of Biological Chemistry. 294(41). 15037–15051. 16 indexed citations

18.

Buisson, Rémi, Michael S. Lawrence, Cyril H. Benes, & Lee Zou. (2017). APOBEC3A and APOBEC3B Activities Render Cancer Cells Susceptible to ATR Inhibition. Cancer Research. 77(17). 4567–4578. 95 indexed citations

19.

Yuan, Yuan, Eliezer M. Van Allen, Larsson Omberg, et al.. (2014). Assessing the clinical utility of cancer genomic and proteomic data across tumor types. Nature Biotechnology. 32(7). 644–652. 214 indexed citations

20.

Lang, Duncan Temple & Michael S. Lawrence. (2011). RGtk2: A Graphical User Interface Toolkit for R. SHILAP Revista de lepidopterología. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact